Clinical utility of custom-designed NGS panel testing in pediatric tumors

ConclusionsUse of somatic NGS panel testing resulted in a significant impact on clinical care, including diagnosis, prognosis, and treatment planning in 78.7% of pediatric patients tested in our institution. Somatic NGS tumor testing should be implemented as part of the routine diagnostic workup of newly diagnosed and relapsed pediatric cancer patients.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research